Saini, Harjot K., and Naranjan S. Dhalla concentration ([Ca 2ϩ ]i) through the Na ϩ /Ca 2ϩ exchanger, the exact mechanisms of its participation in Ca 2ϩ handling by cardiomyocytes are not fully understood. Isolated rat cardiomyocytes were treated with or without agents that are known to modify Ca 2ϩ movements in cardiomyocytes and exposed to an NHE inhibitor, 5-(N-methyl-Nisobutyl)amiloride (MIA). [Ca 2ϩ ]i in cardiomyocytes was measured spectrofluorometrically with fura 2-AM in the absence or presence of KCl, a depolarizing agent. MIA increased basal [Ca 2ϩ ]i and augmented the KCl-induced increase in [Ca 2ϩ ]i in a concentrationdependent manner. The MIA-induced increase in basal [Ca 2ϩ ]i was unaffected by extracellular Ca 2ϩ , antagonists of the sarcolemmal (SL) L-type Ca 2ϩ channel, and inhibitors of the SL Na ϩ /Ca 2ϩ exchanger, SL Ca 2ϩ pump ATPase and mitochondrial Ca 2ϩ uptake. However, the MIA-induced increase in basal [Ca 2ϩ ]i was attenuated by inhibitors of SL Na ϩ -K ϩ -ATPase and sarcoplasmic reticulum (SR) Ca 2ϩ transport. On the other hand, the MIA-mediated augmentation of the KCl response was dependent on extracellular Ca 2ϩ concentration and attenuated by agents that inhibit SL L-type Ca 2ϩ channels, the SL Na ϩ /Ca 2ϩ exchanger, SL Na ϩ -K ϩ -ATPase, and SR Ca 2ϩ release channels and the SR Ca 2ϩ pump. However, the effect of MIA on the KCl-induced increase in [Ca 2ϩ ]i remained unaffected by treatment with inhibitors of SL Ca 2ϩ pump ATPase and mitochondrial Ca 2ϩ uptake. MIA and a decrease in extracellular pH lowered intracellular pH and increased basal [Ca 2ϩ ]i, whereas a decrease in extracellular pH, in contrast to MIA, depressed the KCl-induced increase in [Ca 2ϩ ]i in cardiomyocytes. These results suggest that NHE may be involved in regulation of [Ca 2ϩ ]i and that MIA-induced increases in basal [Ca 2ϩ ]i, as well as augmentation of the KCl-induced increase in [Ca 2ϩ ]i, in cardiomyocytes are regulated differentially.
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IT IS WELL KNOWN that Ca 2ϩ plays a critical role in cardiac excitation-contraction coupling, regulation of myocardial metabolism, and maintenance of cardiac cell integrity (6) . Intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in cardiomyocytes is mainly regulated by sarcolemmal (SL) and sarcoplasmic reticulum (SR) proteins, and the mitochondrion and nucleus are also considered to participate in this process to some extent (6, 17, 42) . SL L-type Ca 2ϩ channels are the major pathways of Ca 2ϩ entry, whereas SL Ca 2ϩ pump ATPase is involved in Ca 2ϩ efflux from cardiomyocytes. The SL Na ϩ /Ca 2ϩ exchanger has been suggested to participate in Ca 2ϩ entry and Ca 2ϩ removal, whereas the SL Na ϩ pump (Na ϩ -K ϩ -ATPase) is considered to regulate [Ca 2ϩ ] i in cardiomyocytes indirectly through participation of the SL Na ϩ /Ca 2ϩ exchanger (6) . In addition, SR Ca 2ϩ ryanodine receptors are associated with Ca 2ϩ release from the SR stores, whereas Ca 2ϩ in SR stores is restored by SR Ca 2ϩ pump ATPase (44) . Involvement of the SL Na ϩ /H ϩ exchanger (NHE) in development of intracellular Ca 2ϩ overload has been suggested in different pathological conditions (3, 11 (26) blocked the exchanger with 5-(N-methyl-Nisobutyl)amiloride (MIA), a known inhibitor of NHE. Cardiomyocytes were treated with agents that are known to modify Ca 2ϩ transport in SL, SR, and mitochondria to investigate the interaction of these agents with MIA to study Ca 2ϩ mobilization. Because low Na ϩ has been shown to stimulate SL Na ϩ /Ca 2ϩ exchange activity in cardiomyocytes (37) , some experiments were performed in the presence of low Na ϩ to investigate the direct contribution of the Na ϩ /Ca 2ϩ exchanger in the NHE-mediated modulation of [Ca 2ϩ ] i . Because NHE is known to promote the efflux of H ϩ generated by myocardial metabolism (33, 36) , pH of isolated cardiomyocytes was measured in the absence and presence of MIA.
METHODS
Isolation of cardiomyocytes. Ventricular myocytes were isolated as described previously (40) . Briefly, male Sprague-Dawley rats (250 -300 g body wt) were anesthetized with a mixture of ketamine (90 mg/kg) and xylazine (9 mg/kg). The hearts were quickly excised, mounted on a Langendorff apparatus, and perfused for 5 min with Ca 2ϩ -free buffer containing (in mM) 90 NaCl, 10 KCl, 1.2 KH2PO4, 5 MgSO 4, 15 NaHCO3, 30 taurine, and 20 glucose and gassed with 95% O2-5% CO2 at 37°C, pH 7.4. The hearts were then switched to the same perfusion medium containing 0.04% collagenase, 0.1% BSA, and 50 M CaCl 2. At the end of a 25-min recirculation period, perfusion was stopped. The ventricles were cut into small pieces and subjected to 15 min of digestion in a fresh collagenase solution containing 1% BSA gassed with 95% O 2-5% CO2 in a shaking water bath at 37°C. The ventricular fragments were triturated gently (twice per minute) with a plastic pipette. The cells from three to four harvests were combined and filtered through 200-m nylon mesh. The cardiomyocytes were resuspended for 5 min in buffers containing gradually increasing extracellular Ca 2ϩ (250, 500, and 750 M) to a final concentration of 1 mM. Cell viability in all experimental groups was determined by the trypan blue (Sigma-Aldrich, Oakville, ON, Canada) exclusion method. A Neubauer chamber was used to count the number of unstained and stained cells and the total number of cells. The final cell suspension consisted of 80 -85% viable, quiescent cardiomyocytes; 3-5% of the cardiomyocytes beat spontaneously. All protocols were approved by the University of Manitoba Animal Care Committee and were conducted in accordance with the standards of the Canadian Council on Animal Care.
Measurement of [Ca 2ϩ ]i. Freshly isolated cardiomyocytes were incubated with 5 M fura 2-AM for 40 min in a buffer (pH 7.4) containing (in mM) 90 NaCl, 10 KCl, 1.2 KH 2PO4, 5 MgSO4, 15 NaHCO 3, 30 taurine, 20 glucose, and 1 CaCl2 and 1% BSA. The cells were washed twice with the same solution for removal of any extracellular dye. The final cell number in the cuvette was adjusted to 3 ϫ 10 5 cells/ml for all the experimental groups. Alterations in fluorescence intensity were monitored by a dual-wavelength spectrofluorometer (model DMX-1100, SLM Instruments, Urbana, IL) adjusted to 340/380-nm excitation, 510-nm emission, 0.95-s integration time, and 1.0-s resolution time. [Ca 2ϩ ]i was calculated as described previously (40) . In some experiments, the cells were pretreated with MIA for 10 min at room temperature before measurement of fluorescence in the presence of KCl or ATP. In all other experiments, fura 2-loaded cells inside the cuvette were treated with different concentrations of MIA for 10 min. No photobleaching of the fluorometric recording was observed during this time period. Modulation of [Ca 2ϩ ]i was determined by incubation of the fura 2-loaded cells in buffer containing the desired concentration of pharmacological agents [except ryanodine and cyclopiazonic acid (CPA)] for 10 min before measurement of fluorescence in the presence and absence of MIA; the cells were treated with ryanodine and CPA for 20 min before determination of [Ca 2ϩ ]i. The concentrations of different pharmacological agents were selected on the basis of our previous experience (37, 41) . The effect of low Na ϩ on MIA-mediated alterations in [Ca 2ϩ ]i was examined by treatment of the cardiomyocytes with Krebs-Henseleit buffer (pH 7.4) containing 70 or 35 mM extracellular Na ϩ for 10 min at room temperature; osmolarity of the solution was maintained by addition of choline chloride, as described elsewhere (41 ] i in cardiomyocytes were measured in the presence of H2791 amiloride, a nonspecific NHE inhibitor (37, 41) , as well as DMA, a specific NHE inhibitor (10 (Table 3) . On the other hand, the KCl-induced increase in [Ca 2ϩ ] i and the MIAmediated augmentation of the KCl-induced response were significantly attenuated by verapamil and diltiazem (Table 3) . (Fig. 3, B  and D) . In addition, MIA-mediated augmentation of the KClinduced response was significantly depressed by treatment with these agents (Table 6, Fig. 3, C and D) . Preincubation with ryanodine, CPA, and caffeine had no effect on basal [ ] i and augmentation of the KCl-mediated increase, we investigated the effects of extracellular pH and MIA on intracellular pH. Reduction of extracellular pH from 7.4 to 5.5 decreased intracellular pH (Fig. 4A) . Reduction of pH to 5.5 significantly increased basal [Ca 2ϩ ] i (Fig. 4B) . On the other hand, reduction of extracellular pH from 7.4 to 6.5 did not significantly affect the KCl-induced increase in [Ca 2ϩ ] i , which was significantly decreased at pH 6.0 and 5.5 (Fig. 4C) . MIA (1-10 M) significantly reduced pH in cardiomyocytes in HCO 3 Ϫ -free buffer (Fig. 4D ) and increased basal [Ca 2ϩ ] i under the experimental conditions used for pH measurements (Fig.  4E) . A highly significant linear relation was observed for changes in basal [Ca 2ϩ ] i and decrease in pH, in contrast to the KCl-induced increase in [Ca 2ϩ ] i and decrease in pH in an acidic environment and in the presence of MIA (Fig. 5F ). In another set of experiments using three separate preparations and HCO 3 Ϫ -containing buffer, intracellular pH was 7.12 Ϯ 0.03 (29, 35) , it is likely that the MIA-mediated reduction in intracellular pH is responsible for such an increase in basal [Ca 2ϩ ] i . Orchard et al. (30) showed that acidosis facilitates the spontaneous SR Ca 2ϩ release in rat myocardium, which can be abolished by ryanodine and caffeine. Furthermore, acidosis has been shown to reduce SR Ca 2ϩ uptake (9) and affect the L-type Ca 2ϩ channels and Na ϩ /Ca 2ϩ exchange activity (12, 19) . In view of the linear relation between the decrease in intracellular pH and basal [Ca 2ϩ ] i observed in this study, it appears that the increase in basal [Ca 2ϩ ] i by NHE inhibition may be a consequence of the decrease in pH with a subsequent release of Ca 2ϩ from SR, as well as changes in SL Ca 2ϩ transport. MIA was found to exert no direct effect on SR Ca 2ϩ uptake or SR Ca 2ϩ release under in vitro conditions (unpublished observations). Although the ] i may be a consequence of the direct action of ouabain on SL Na ϩ -K ϩ -ATPase and the indirect action of MIA on the SL Na ϩ /Ca 2ϩ exchanger. The contribution of alterations in intracellular pH cannot be ruled out, inasmuch as ouabain has been shown to significantly decrease pH in the presence and absence of an NHE inhibitor (20) .
RESULTS
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Role of SL
The results of the present study suggest that MIA-mediated alterations in [Ca 2ϩ ] i mobilization are regulated differently in quiescent and depolarized cardiomyocytes. Although NHE is an important SL site for promoting the efflux of H ϩ and, thus, leads to the decrease of metabolic acidosis due to its inhibition by agents such as MIA (33, 43) , its contribution under normal physiological conditions is controversial (4, 7, 18 3 Ϫ in the perfusion medium.
MIA was selected for the present study because it is available and does not interfere with fura 2 excitation and emission wavelengths. MIA (1-10 M) is considered to inhibit NHE specifically, inasmuch as its IC 50 for NHE was 14 M, whereas its IC 50 values for the Na ϩ /Ca 2ϩ exchanger, Ca 2ϩ pump, and Na ϩ pump were 84, 70, and Ͼ300 M, respectively (27) . Because DMA, another specific inhibitor of NHE (10), interferes with fura 2, the values for basal [Ca 2ϩ ] i and the KCl-induced [Ca 2ϩ ] i response due to this agent were corrected appropriately. Similar interference in fura 2 excitation wavelength was observed in the previous study (39) in the presence of ethylisopropylamiloride, which has a 10-fold higher potency than DMA to block NHE (13) . Although cardiotoxicity of amiloride derivatives has limited their use as an experimental tool (27) , no such effect of MIA on cardiomyocyte viability was observed in the present study. Nonetheless, MIA-induced intracellular Ca 2ϩ overload in cardiomyocytes, as observed in this study, can be considered to explain the cardiotoxic effects of high concentrations of amiloride derivatives (27) . Other investigators used benzoylguaninidine derivatives (cariporide) and bicyclic guanidines (zoniporide, SMP-300, SM-20220, and SM-20550) as NHE inhibitors (22) to study their effects on cardiac function but obtained varying results. Such differences in results seem to depend on the animal model, optimal dose, timing of drug delivery, and disparity in selection of the end point (10, 11) . However, the results of the clinical trials with some NHE inhibitors in patients with ischemic heart disease were not promising (14) . Nonetheless, extrapolation of the MIA-induced increase in basal [Ca 2ϩ ] i and augmentation of the KCl-mediated increase in [Ca 2ϩ ] i in cardiomyocytes to the cerebrovascular system suggests vasoconstriction and cerebral spasm in the brain on inhibition of the SL NHE. Elevated Ca 2ϩ in the brain has been shown to produce neuronal death (24) . Intracellular Ca 2ϩ overload can also have deleterious effects on cardiac and vascular cells over a prolonged period of treatment with NHE inhibitors (2, 25) . In addition, the MIA-induced decrease in intracellular pH also indicates the potential for NHE inhibitors to produce intracellular acidosis, which may be detrimental to cardiac function.
Because we did not compare the effects of MIA with those of some of the newer NHE inhibitors such as cariporide, it is difficult to comment on the clinical significance of the results presented in this study. However, cariporide has been reported not to depress the anoxia-induced intracellular Ca 2ϩ overload (39) . Similarly, the metabolic inhibition-mediated increase in intracellular Na ϩ and Ca 2ϩ was not prevented by cariporide (38) . On the other hand, chemical hypoxia-mediated Ca 2ϩ accumulation was attenuated by cariporide (32) . Although cariporide had a beneficial effect on heart function in a clinical trial (23) , it increased the incidence of stroke. Thrombotic stroke and platelet aggregation in cariporide-treated patients (23) were apparently not identified as effects of NHE inhibitors. Thus a great deal of caution should be exercised in interpretation of the observations with MIA in this study in terms of explaining the potential toxicity of the newer NHE inhibitors.
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